Graves Disease Market Research Report by Treatment (Anti-Thyroid Medication, Radioactive Iodine Therapy, and Surgery), Diagnosis, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

Graves Disease Market Research Report by Treatment (Anti-Thyroid Medication, Radioactive Iodine Therapy, and Surgery), Diagnosis, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
256 Pages
January 2023
Region: Global
360iResearch™
ID: 5674290

UP TO €854EUR$895USD£750GBP OFF until Mar 31^st 2023

The Global Graves Disease Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Graves Disease Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Graves Disease Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Graves Disease Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Graves Disease Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Graves Disease Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Graves Disease Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment, the market is studied across Anti-Thyroid Medication, Radioactive Iodine Therapy, and Surgery.
Based on Diagnosis, the market is studied across Blood Sample, Imaging Tests, Radioactive Iodine Uptake, and Ultrasound.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Graves Disease Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Graves Disease Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Graves Disease Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Graves Disease Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Graves Disease Market, including Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Horizon Therapeutics PLC, Immunovant, Inc., Lupin Limited, Medtronic PLC, Merck KGaA, Mylan N.V., Pfizer, Inc., RLC Labs, Inc., and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Graves Disease Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Graves Disease Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Graves Disease Market?
4. What is the competitive strategic window for opportunities in the Global Graves Disease Market?
5. What are the technology trends and regulatory frameworks in the Global Graves Disease Market?
6. What is the market share of the leading vendors in the Global Graves Disease Market?
7. What modes and strategic moves are considered suitable for entering the Global Graves Disease Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of hyperthyroidism disease
5.1.1.2. Rising awareness regarding disease among the population
5.1.1.3. Government initiatives to improve disease treatment
5.1.2. Restraints
5.1.2.1. Concern with serious complication associated with disease
5.1.3. Opportunities
5.1.3.1. Surging research and development of grave disease treatment
5.1.3.2. Availability of new radioiodine therapy and medications
5.1.4. Challenges
5.1.4.1. Increasing recalls of thyroid drugs
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Graves Disease Market, by Treatment
6.1. Introduction
6.2. Anti-Thyroid Medication
6.3. Radioactive Iodine Therapy
6.4. Surgery

7. Graves Disease Market, by Diagnosis
7.1. Introduction
7.2. Blood Sample
7.3. Imaging Tests
7.4. Radioactive Iodine Uptake
7.5. Ultrasound

8. Americas Graves Disease Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Graves Disease Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Graves Disease Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. AbbVie Inc.
12.3. Amgen Inc.
12.4. Bayer AG
12.5. Eli Lilly and Company
12.6. F. Hoffmann-La Roche Ltd.
12.7. Horizon Therapeutics PLC
12.8. Immunovant, Inc.
12.9. Lupin Limited
12.10. Medtronic PLC
12.11. Merck KGaA
12.12. Mylan N.V.
12.13. Pfizer, Inc.
12.14. RLC Labs, Inc.
12.15. Thermo Fisher Scientific Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL GRAVES DISEASE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL GRAVES DISEASE MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL GRAVES DISEASE MARKET DYNAMICS
FIGURE 11. GLOBAL GRAVES DISEASE MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT, 2030
FIGURE 15. GLOBAL GRAVES DISEASE MARKET SIZE, BY ANTI-THYROID MEDICATION, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL GRAVES DISEASE MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2022 VS 2030 (%)
FIGURE 19. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY DIAGNOSIS, 2030
FIGURE 21. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD SAMPLE, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL GRAVES DISEASE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
FIGURE 25. AMERICAS GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 26. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 27. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 28. AMERICAS GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 29. ARGENTINA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. BRAZIL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. CANADA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. MEXICO GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 35. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 36. UNITED STATES GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 37. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 39. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 40. ASIA-PACIFIC GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 41. AUSTRALIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. CHINA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. INDIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. INDONESIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. JAPAN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. MALAYSIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. PHILIPPINES GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. SINGAPORE GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. SOUTH KOREA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. TAIWAN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. THAILAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. VIETNAM GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 57. DENMARK GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. EGYPT GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. FINLAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. FRANCE GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. GERMANY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. ISRAEL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. ITALY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. NETHERLANDS GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. NIGERIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. NORWAY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. POLAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. QATAR GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. RUSSIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. SPAIN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. SWEDEN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. SWITZERLAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. TURKEY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. GLOBAL GRAVES DISEASE MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 79. GLOBAL GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 80. GLOBAL GRAVES DISEASE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables
TABLE 1. GLOBAL GRAVES DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GRAVES DISEASE MARKET SIZE, BY ANTI-THYROID MEDICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GRAVES DISEASE MARKET SIZE, BY ANTI-THYROID MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GRAVES DISEASE MARKET SIZE, BY ANTI-THYROID MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GRAVES DISEASE MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GRAVES DISEASE MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GRAVES DISEASE MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD SAMPLE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GRAVES DISEASE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GRAVES DISEASE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GRAVES DISEASE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 39. CANADA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 40. CANADA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. CANADA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 42. MEXICO GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. MEXICO GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 56. CHINA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 57. CHINA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. CHINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 59. INDIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 60. INDIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. INDIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 65. JAPAN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 66. JAPAN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. JAPAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 68. MALAYSIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 71. PHILIPPINES GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 72. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 74. SINGAPORE GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. SINGAPORE GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. SINGAPORE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 77. SOUTH KOREA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 80. TAIWAN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 81. TAIWAN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. TAIWAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 83. THAILAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 84. THAILAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. THAILAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 86. VIETNAM GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. VIETNAM GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. VIETNAM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 93. DENMARK GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. DENMARK GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. DENMARK GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 96. EGYPT GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 97. EGYPT GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. EGYPT GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 99. FINLAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 100. FINLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. FINLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 102. FRANCE GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 103. FRANCE GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. FRANCE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 105. GERMANY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. GERMANY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 108. ISRAEL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 109. ISRAEL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. ISRAEL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 111. ITALY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. ITALY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. ITALY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 117. NIGERIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. NIGERIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. NIGERIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 120. NORWAY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. NORWAY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. NORWAY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 123. POLAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. POLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. POLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 126. QATAR GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. QATAR GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. QATAR GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 132. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 135. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 138. SPAIN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. SPAIN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 141. SWEDEN GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 142. SWEDEN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. SWEDEN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 144. SWITZERLAND GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 145. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 147. TURKEY GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 149. TURKEY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 156. GLOBAL GRAVES DISEASE MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 157. GLOBAL GRAVES DISEASE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 158. GLOBAL GRAVES DISEASE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 159. GLOBAL GRAVES DISEASE MARKET RANKING, BY KEY PLAYER, 2022
TABLE 160. GLOBAL GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 161. GLOBAL GRAVES DISEASE MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 162. GLOBAL GRAVES DISEASE MARKET MERGER & ACQUISITION
TABLE 163. GLOBAL GRAVES DISEASE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 164. GLOBAL GRAVES DISEASE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 165. GLOBAL GRAVES DISEASE MARKET INVESTMENT & FUNDING
TABLE 166. GLOBAL GRAVES DISEASE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 167. GLOBAL GRAVES DISEASE MARKET: LICENSE & PRICING